PREVALENCE OF POLYMORPHISMS IN WARFARIN METABOLISM-RELATED GENES AMONG THE KAZAKH POPULATION
Objective: The study aims to perform a comparative analysis of population frequencies of minor alleles of polymorphisms in the genes CYP2C9 *2 (rs1799853), *3 (rs1057910), *5 (rs28371686), and *6 (rs9332131); CYP2C19 (rs3814637), VKORC1 (rs9934438), CYP4F2 (rs2108622), GGCX (rs11676382), as well as GWAS-associated variants related to resistance to vitamin K antagonists in an ethnically homogeneous Kazakh population, and to assess the distribution and perform a comparative analysis of metabolic phenotypes ("metabolizer types") in comparison with previously studied global populations.
Materials and Methods: The research was based on genomic analysis data from 1,900 conditionally healthy individuals of Kazakh ethnicity, obtained within the framework of the 7th Framework Programme of the European Union under Grant Agreement No. 282540.
Results: A high frequency of the minor allele of the "Asian" variant rs11676382 in the GGCX gene was identified in the Kazakh population (14.4%) compared to European, East Asian, and South Asian groups. It may indicate a potentially more pronounced impact of this polymorphism on individual warfarin dosing requirements in individuals of Kazakh ethnicity.
In the studied Kazakh group, the identified phenotypes and frequencies of metabolizers for CYP2C9 *2 (rs1799853) and *3 (rs1057910) alleles were as follows: 1/1 (80.1%), 1/3 (13.0%), 3/3 (0.25%), 1/2 (6.0%), 2/3 (0.40%), and 2/2 (0.25%). Normal metabolizers (*2 and *3 alleles) comprised 80.1%, intermediate metabolizers - 19.0%, and slow metabolizers - 0.9%.
For CYP2C9 *5 (rs28371686) and *6 (rs9332131) alleles, the phenotypes and metabolizer frequencies were: 1/1 (90.0%), 1/6 (6.7%), 1/5 (2.9%), 5/6 (0.3%), and 5/5 (0.1%). Normal metabolizers for *5 and *6 alleles accounted for 90.0%, intermediate - 9.6%, and slow - 0.4%.
Conclusion. The results provide additional pharmacogenetic database information for Central Asia, facilitating a better understanding of warfarin pharmacokinetics and pharmacodynamics for individualized warfarin dosing in patients undergoing heart surgery in Kazakhstan.
Number of Views: 838
Category of articles:
Original article
Bibliography link
Murtazaliyeva A.V., Berezinа G.M., Svyatova G.S., Yesset M.S., Burabayeva A.T. Prevalence of polymorphisms in warfarin metabolism-related genes among the Kazakh population // Nauka i Zdravookhranenie [Science & Healthcare]. 2025. Vol.27 (3), pp. 16-26. doi 10.34689/SH.2025.27.3.002Related publications:
GENETIC VARIANTS IN LIPID-ASSOCIATED GENES IN THE KAZAKHSTANI COHORT WITH ATHEROSCLEROSIS AND HYPERTRIGLYCERIDEMIA
CLONAL HEMATOPOIESIS WITH INDETERMINATE POTENTIAL IN TET2 AND DNMT3A AMONG KAZAKHSTANI INDIVIDUALS WITH ATHEROSCLEROTIC DISEASE
PRELIMINARY ANALYSIS AND ASSESSMENT OF THE HEALTH STATUS OF THE DESCENDANTS OF PERSONS EXPOSED TO RADIATION, LIVING IN THE BESKARAGAI DISTRICT OF THE ABAY REGION
PRELIMINARY ANALYSIS OF THE HEALTH STATUS AND RADIATION DOSES OF RESIDENTS OF THE ABAY DISTRICT OF THE ABAY REGION, WHO ARE DESCENDANTS OF PERSONS EXPOSED TO RADIATION DUE TO NUCLEAR WEAPONS TESTS
TRENDS AND DISPARITIES IN CANCER MORBIDITY IN KAZAKHSTAN: A REGIONAL AND AGE-BASED ANALYSIS FOR 2014-2024